I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Breitkreutz, Iris
19
results:
Search for persons
X
Format
Online (19)
Mediatypes
Articles (Online) (11)
OpenAccess-fulltext (8)
Sorted by: Relevance
Sorted by: Year
?
1
Concurrent light chain amyloidosis and proximal tubulopathy..:
Feurstein, Simone
;
Zoller, Julian
;
Schwab, Constantin
...
eJHaem. 3 (2022) 4 - p. 1377-1380 , 2022
Link:
https://doi.org/10.1002/..
?
2
P-188: Carfilzomib, lenalidomide, and dexamethasone followe..:
Baertsch, Marc-A.
;
Fougereau, Mathilde
;
Hielscher, Thomas
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S140-S141 , 2021
Link:
https://doi.org/10.1016/..
?
3
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Sa..:
Baertsch, Marc-Andrea
;
Fougereau, Mathilde
;
Hielscher, Thomas
...
Cancers. 13 (2021) 18 - p. 4706 , 2021
Link:
https://doi.org/10.3390/..
?
4
The orally available multikinase inhibitor regorafenib (BAY..:
Breitkreutz, Iris
;
Podar, Klaus
;
Figueroa-Vazquez, Vianihuini
...
Annals of Hematology. 97 (2018) 5 - p. 839-849 , 2018
Link:
https://doi.org/10.1007/..
?
5
Dose‐intensified bendamustine followed by autologous periph..:
Breitkreutz, Iris
;
Becker, Natalia
;
Benner, Axel.
...
Hematological Oncology. 34 (2015) 4 - p. 200-207 , 2015
Link:
https://doi.org/10.1002/..
?
6
Preclinical efficacy of sepantronium bromide (YM155) in mul..:
Wagner, Verena
;
Hose, Dirk
;
Seckinger, Anja
...
Oncotarget. 5 (2014) 21 - p. 10237-10250 , 2014
Link:
https://doi.org/10.18632..
?
7
High dose of Zoledronic acid inhibits both osteoclasts and ..:
Pozzi, Samantha
;
Hideshima, Teru
;
Vallet, Sonia
...
Bone. 42 (2008) - p. S63 , 2008
Link:
https://doi.org/10.1016/..
?
8
Retraction: Fatty acid synthase is a novel therapeutic targ..:
Okawa, Yutaka
;
Hideshima, Teru
;
Ikeda, Hiroshi
...
British Journal of Haematology. 141 (2008) 5 - p. 659-671 , 2008
Link:
https://doi.org/10.1111/..
?
9
Targeting MEK1/2 blocks osteoclast differentiation, functio..:
Breitkreutz, Iris
;
Raab, Marc S.
;
Vallet, Sonia
...
British Journal of Haematology. 139 (2007) 1 - p. 55-63 , 2007
Link:
https://doi.org/10.1111/..
?
10
Effect of CD34+ cell dose on hematopoietic reconstitution a..:
Klaus, Jens
;
Herrmann, Doris
;
Breitkreutz, Iris
...
European Journal of Haematology. 78 (2006) 1 - p. 21-28 , 2006
Link:
https://doi.org/10.1111/..
?
11
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Sa..:
Baertsch, Marc-Andrea
;
Fougereau, Mathilde
;
Hielscher, Thomas
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472377/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
12
Targeting PKC: a novel role for beta-catenin in ER stress a..:
Raab, Marc S
;
Breitkreutz, Iris
;
Tonon, Giovanni
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644079. , 2009
Link:
http://www.ncbi.nlm.nih...
?
13
Retraction: Fatty acid synthase is a novel therapeutic targ..:
Okawa, Yutaka
;
Hideshima, Teru
;
Ikeda, Hiroshi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408665. , 2008
Link:
http://www.ncbi.nlm.nih...
?
14
Targeting PKC in multiple myeloma: in vitro and in vivo eff..:
Podar, Klaus
;
Raab, Marc S
;
Zhang, Jing
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794057. , 2007
Link:
http://www.ncbi.nlm.nih...
?
15
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis..:
Vallet, Sonia
;
Raje, Noopur
;
Ishitsuka, Kenji
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077320. , 2007
Link:
http://www.ncbi.nlm.nih...
1-15